We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Management of melanoma metastases in the brain.
- Authors
Rutkowski, Piotr; Kiprian, Dorota; Dudzisz-Śledź, Monika; Świtaj, Tomasz; Michalik, Radosław; Spałek, Mateusz; Kozak, Katarzyna; Mandat, Tomasz
- Abstract
The basic principle for the diagnosis of melanoma metastases in the brain should be the management of multidisciplinary teams including at least a neurosurgeon, radiotherapist and clinical oncologist experienced in the treatment of melanoma and melanoma metastases in the CNS. Detection of brain lesions is associated with poor prognosis; metastases in the brain are the cause of death in 20-50% patients, and symptomatic tumours are a direct cause of death in about 90% patients. Treatment of melanoma with CNS metastases may include local management and/or systemic and symptomatic treatment. In the last 5 years, 10 new advanced melanoma drugs have been registered in Europe. Two-drug therapy anti-PD-1 and anti-CTLA-4 (nivolumab with ipilimumab) is the treatment of choice for asymptomatic melanoma metastases in the brain, while in the presence of BRAF mutations and asymptomatic metastases systemic treatment with BRAFi and MEKi may be the first-choice treatment.
- Subjects
MELANOMA; METASTASIS; NEUROSURGEONS; MELANOMA treatment; MELANOMA prognosis
- Publication
Nowotwory, 2019, Vol 69, Issue 3/4, p86
- ISSN
0029-540X
- Publication type
Article
- DOI
10.5603/NJO.2019.0018